Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP: Qutenza in Painful Diabetic Peripheral Neuropathy
NCT01533428Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2012
- Primary completion
- Feb 2014
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capsaicin 8% patch in diabetic peripheral neuropathy (DPN), sponsored by Astellas Pharma. Started Feb 2012; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01533428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01533428.